Gainers
- Tivic Health Systems TIVC shares increased by 75.3% to $0.46 during Friday's pre-market session. The company's market cap stands at $2.8 million.
- Doximity DOCS stock rose 29.94% to $56.42. The company's market cap stands at $10.4 billion. As per the press release, Q2 earnings came out yesterday.
- Fortrea Holdings FTRE stock rose 26.31% to $22.8. The market value of their outstanding shares is at $2.0 billion. As per the news, the Q3 earnings report came out today.
- Tenaya Therapeutics TNYA shares moved upwards by 20.39% to $3.01. The company's market cap stands at $237.4 million. The company's, Q3 earnings came out 2 days ago.
- Indaptus Therapeutics INDP stock rose 15.11% to $1.37. The company's market cap stands at $13.9 million.
- CytomX Therapeutics CTMX shares rose 14.99% to $1.15. The company's market cap stands at $89.8 million. As per the news, the Q3 earnings report came out yesterday.
Losers
- ProPhase Labs PRPH stock declined by 51.8% to $0.69 during Friday's pre-market session. The company's market cap stands at $13.1 million.
- Maravai LifeSciences MRVI stock decreased by 40.06% to $4.7. The market value of their outstanding shares is at $665.3 million. As per the news, the Q3 earnings report came out yesterday.
- Evolent Health EVH stock decreased by 38.75% to $15.05. The market value of their outstanding shares is at $1.7 billion. As per the press release, Q3 earnings came out yesterday.
- Agilon Health AGL stock fell 33.34% to $1.86. The market value of their outstanding shares is at $765.3 million. As per the news, the Q3 earnings report came out yesterday.
- AlloVir ALVR shares declined by 29.7% to $0.69. The market value of their outstanding shares is at $79.6 million.
- Revance Therapeutics RVNC shares decreased by 25.61% to $4.3. The company's market cap stands at $447.9 million. The company's, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in